Skip to main content

Jim Cramer Explains How Moderna Stock Trades

Publish date:
Video Rating:
Video Duration:

While Moderna  (MRNA) - Get Free Report stock traded over 3% lower to $466.56, the stock soared 17% higher Monday following Swiss and Australian approval of its COVID vaccine. 

The stock was bolstered premarket and in earlier trading by a medical journal suggesting that not only is Moderna's mRNA-1273 coronavirus vaccine more effective in preventing Delta variant infections, but it could also be used as booster shot for patients who've already received the two-dose regime from either Pfizer  (PFE) - Get Free Report or Moderna, according to TheStreet's Martin Baccardax. 

Jim Cramer explained how Moderna stock trades in the video above. 

Recap TheStreet Live: Everything Jim Cramer Is Watching 8/10/21

Related Videos